Pantothenate Kinase-Associated Neurodegeneration with Increased Lentiform Nuclei Cerebral Blood Flow

References

1. ↵
   Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33–40

   CrossRefPubMedWeb of Science
2. Sener RN. Pantothenate kinase-associated neurodegeneration: MR imaging, proton MR spectroscopy, and diffusion MR imaging findings. AJNR Am J Neuroradiol 2003;24:1690–93

   Abstract/FREE Full Text
3. Guillerman RP. The Eye-of-the-tiger sign. Radiology 2000;217:895–96

   PubMed
4. ↵
   Savoiardo M, Halliday WC, Nardocci N, et al. Hallervorden-Spatz disease: MR and pathologic findings. AJNR Am J Neuroradiol 1993;14:155–62

   Abstract/FREE Full Text
5. ↵
   Swaiman KF. Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:102–108

   CrossRefPubMedWeb of Science
6. ↵
   Kuji I, Sumiya H, Niida Y, et al. Age-related changes in the cerebral distribution of ^99mTc-ECD from infancy to adulthood. J Nucl Med 1999;40:1818–23

   Abstract/FREE Full Text
7. ↵
   Perry TL, Norman MG, Yong VM, et al. Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol 1985;18:482–89

   CrossRefPubMedWeb of Science
8. ↵
   Umemura A, Jagii JL, Dolinskas CA, et al. Pallidal deep brain stimulation for longstanding severe generalized dystonia in Hallervorden-Spatz syndrome. J Neurosurg 2004;100:706–709

   CrossRefPubMed